Certain Aerogen R&D initiatives are co-funded by the European Regional Development Fund and Enterprise Ireland as part of the Border, Midland and Western Regional Operational Programme 2014-2020. This R&D aims to develop novel nebulizer systems aimed at increasing R&D activity which will drive company development.
What we have achieved in our laboratories is award-winning precision targeted aerosol drug delivery that outperforms traditional systems.
Over 3 million patients in over 75 countries worldwide have benefitted from our unique palladium vibrating mesh technology.
Our unique palladium vibrating mesh technology, Aerogen Vibronic® is a breakthrough in aerosol drug delivery and is at the heart of all our products.
The central aperture plate is just 5mm in diameter and is perforated with 1000 precision formed holes, that vibrate at 128,000 times per second, to produce the optimum particle size for deep lung penetration.
Innovation and creativity are at the core of every product development programme, while Aerogen’s structured 5 stage gate development process ensures that projects are executed in a methodical and cost effective manner.
Aerogen entered into an exclusive collaboration with Philips Healthcare for the development of the NIVO, customized for use, in non-invasive ventilation (NIV). The NIVO is designed for use with Philips oro-nasal facemask & provides patients with all the benefits of Aerogen’s aerosol drug delivery technology in an NIV setting.
Aerogen technology has been integrated into leading mechanical life support ventilators, including GE Healthcare’s Engström Carestation. GE Healthcare recognizes that Aerogen technology adds value to their ventilator, offering their customers the most advanced aerosol drug delivery technology available in the critical care market.
As a trusted partner for hospitals and clinicians since 1838, MAQUET is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and ventilation in critical care. Choosing to work with Aerogen, Maquet incorporated Aerogen’s aerosol drug delivery technology into a customized Aerogen module designed specifically for the SERVO-i, SERVO-u and SERVO-n. This one-touch module makes it even easier for the clinician to set up a patient on the Aerogen Solo in the ICU.
Both the Hamilton SI and G5 ventilators offer Aerogen’s integrated aerosol drug delivery technology. Hamilton Medical, along with GE Healthcare and Maquet recognize the benefits that come from integrating Aerogen technology at source.
Aerogen is the global partner for many of the world’s leading ventilation companies including Covidien who supply “Aerogen ready” ventilators to hospitals worldwide. “We are committed to improving lives through our innovative medical technologies and solutions. That’s why we partner with hospitals, health systems and healthcare providers so they can deliver the best care possible to patients and their families.”
Source : http://www.medtronic.com/covidien/about
Aerogen is the global partner for many of the world’s leading ventilation companies including Drager who supply “Aerogen ready” ventilators to hospitals worldwide. “As an international leader in medical and safety technology, Dräger develops innovative equipment and solutions people the world over trust. No matter where Dräger products are used: it’s always about life. Whether for use in clinical, industrial or mining applications, in firefighting or rescue services, Dräger products protect, support and save lives.”
It is a fast, efficient, simple-to-use device developed specifically for the millions of patients worldwide who require respiratory aerosol drug delivery therapy in and away from the home. The Aeroneb® Go can be used by pediatric as well as adult patients and is ideal for conditions such as asthma and chronic obstructive pulmonary disease (COPD). It can be used with a mouth piece or an aerosol mask.